EAAT4 Antibodies

Santa Cruz Biotechnology offers a broad range of EAAT4 monoclonal antibodies for investigating excitatory amino acid transporter 4 (EAAT4). EAAT4 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EAAT4 plays a critical role in regulating glutamate levels in the central nervous system, contributing to neurotransmission and preventing excitotoxicity. Proper EAAT4 functioning is essential for maintaining synaptic balance and overall neuronal health, making it a significant focus in studies related to neurodegenerative diseases and neurological disorders. Understanding EAAT4 expression and activity patterns can provide valuable information about cellular responses in various neurological conditions. Investigating EAAT4 localization and interactions helps reveal its role in maintaining glutamate homeostasis and synaptic plasticity. Research focusing on EAAT4 continues to uncover new aspects of neurotransmitter regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge neuroscience research, enabling scientists to advance our understanding of neurological health and disease mechanisms.